Research Article
Plasma Total Cysteine and Cardiovascular Risk Burden: Action and Interaction
Table 1
Clinical and biochemical characteristics according to risk factors burden.
| | All patients () | Group 0 () | Group 1 () | Group 2 () | Group 3 () |
| Age (years) | 53 [43; 63] | 44 [34; 53] | 49 [39; 60] | 59 [50; 67] | 59 [53; 66] | Male gender (%) | 169 (56%) | 35 (43%) | 51 (54%) | 52 (65%) | 31 (65%) | Body mass index (kg/m2) | 25 [22; 28] | 22 [21; 25] | 25 [23; 27] | 25 [23; 28] | 28 [26; 31] | Fasting glucose (mg/dL) | 93 [84; 109] | 87 [80; 89] | 89 [82; 96] | 98 [87; 125] | 120 [100; 147] | Total cholesterol (mg/dL) | 200 [176; 230] | 195 [171; 226] | 197 [173; 216] | 204 [179; 248] | 217 [185; 244] | HDL cholesterol (mg/dL) | 56 [47; 67] | 63 [51; 73] | 56 [50; 65] | 50 [42; 62] | 52 [46; 66] | LDL cholesterol (mg/dL) | 117 [96; 146] | 104 [84; 137] | 118 [102; 141] | 122 [98; 166] | 115 [98; 164] | Triglycerides (mg/dL) | 106 [71; 145] | 85 [55; 127] | 92 [61; 124] | 127 [91; 174] | 129 [96; 212] | Creatinine (mg/dL) | 0.83 [0.70; 0.98] | 0.83 [0.72; 0.99] | 0.79 [0.68; 0.97] | 0.84 [0.70; 0.99] | 0.89 [0.72; 1.01] | Serum folate (ng/mL) | 6.1 [4.6; 8.1] | 6.2 [4.8; 8.8] | 6.1 [4.5; 7.8] | 5.3 [4.1; 7.7] | 7.5 [5.5; 9.9] | Vitamin B12 (pg/mL) | 396 [284; 530] | 465 [367; 588] | 362 [275; 450] | 386 [265; 532] | 365 [230; 501] |
|
|
Data are expressed as median value and interquartile range [I; III] or number of patients (percentage).
|